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Readmission reduction is at the focus of health care systems worldwide in efforts to improve efficiency across care
settings. Yet, setting targets for readmission reduction is complicated due to inconsistencies in evidence pointing to
effective organization-wide interventions and because of inverse incentives (such as maintaining high occupancy
rates). Nonetheless, readmission reduction is one of the few quality measures that, if implemented properly, can
serve as a catalyst for system integration. Appropriate mechanisms should be applied to hospitals as well as
ambulatory settings to ensure that accountability is assigned to all stakeholders.
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Setting acceptable rates for readmission reduction and
identification of effective interventions to achieve prede-
termined goals have been the focus of health care policy
and practice for several decades. Recently, regulators in
Europe, the United States, and Israel, have directed unpre-
cedented incentives in an effort to tackle readmissions.
Several converging trends may explain why readmis-
sion reduction has become a focal point in health policy
worldwide. Health systems are facing considerable strain
associated with population aging and ensuing chronic
disease at younger ages. These phenomena, coupled with
the economic crisis, require health systems to increas-
ingly pursue effectiveness and waste reduction in the
management of population health. The promise of pre-
venting a large proportion of the annual admissions is
naturally quite compelling in these times.
In addition, the last decades have seen an increasing
emphasis on quality measurement and quality improve-
ment as key aspects of efficient health systems manage-
ment worldwide. Variability in the rates of readmission
[1] alludes to the potential for improvement in this care
domain. Measurement of hospital readmission within
30 days of discharge is often used as a quality measure* Correspondence: rbalicer@clalit.org.il
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reproduction in any medium, provided the orbecause it is relatively easy and inexpensive to measure,
and may reflect poor quality of care during, or immedi-
ately after, discharge. Reducing the rates of readmissions,
especially those that can be deemed as "avoidable", offers
the prospect of improving care while simultaneously
reducing health care costs. However, most of the current
literature does not justify the use of rates of readmission
as an indicator of the quality of hospital care [2,3].
Despite the lack of consensus in defining "avoidable"
readmissions [4], it is generally agreed that about 10–20%
of early (commonly measured as 30-day) readmissions are
unjustified, suggesting that we should not overlook the
importance of reducing unnecessary readmissions. The
growing interest in readmission reduction, as reflected by
recent international policy mainly in the U.S. and the U.
K., is also evident in the proliferation of studies in this
field, which has more than doubled in 2011–2012 com-
pared to yearly rates of publication over the past decade.Readmission reduction – what really works?
The paper by Benbassat et al. [5] provides an important
summary of decades of published assessments of the
effectiveness of interventions for reducing readmissions
in a multitude of health care settings (including hospitals
and ambulatory care settings). With a wealth of pub-
lished data, and a comprehensive compilation of system-
atic reviews markedly different from one another in
methodology and setting, the paper [5] is an importantLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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i.e., What really works in reducing readmissions?
Yet, there are several issues and limitations that must
be acknowledged when considering the translation of
published evidence into actual health care policy and
practice. First, given the breadth of literature in the area,
a meta-review is an exceptionally valuable tool for sum-
marizing findings and providing direction to evidence-
based policy and practice. However, meta-reviews are
contingent on studies previously summarized in meta-
analyses and therefore are subject to a publication lag
and are affected by the types of inclusion criteria
employed in each of the summarized reviews. In the
field of readmission interventions, recent studies have
shed new light on the effectiveness of some integrative
interventions. Moreover, replications of controlled trials
in larger demonstration or prospective cohort studies
provide invaluable evidence on the generalizability and
large scale implacability of the suggested interventions.
Recent Randomized Controlled Trials [6,7] that have
been replicated in larger cohort studies [8,9] present the
positive effects of an in-hospital discharge planning
intervention, coupled with a post-discharge follow-up
component.
Second, most studies of readmissions focus on single
conditions as the reason for the index hospitalization
and often limit the analysis to readmissions for clinically
related reasons. Chronic heart failure (CHF), chronic
obstructive pulmonary disease (COPD), and pneumonia
are the three most commonly studied diseases associated
with readmissions. This focus on a specific disease is
clinically appealing, as the root cause related to the
readmission is often sought. However, readmissions are
rarely caused by factors solely related to the index
admission [10] and multimorbidity is a major risk factor
for readmission, calling for a broader, non-disease-
specific assessment of the risks and solutions. A typical
patient admitted with CHF could potentially have six
additional serious chronic illnesses and complex socially
related characteristics, which are just as likely causes of
readmission.
Most importantly, too few studies to date have assessed
the impact of multi-disciplinary integrated interventions
extending from the hospital to the family physician prac-
tice and patient home. Most current literature focuses
either on in-hospital [11] or ambulatory care [12,13] inter-
ventions. Yet, the breadth of risk factors identified in the
literature, spanning health care setting characteristics [14],
availability of health care resources [15], area level patterns
of health care practice [16], and care trajectories [17,18]
point to the need for developing and testing interventions
in real world settings in various population groups. More-
over, very few interventions have been attempted in inte-
grative care systems such as Clalit Health Services in Israelor Kaiser Permanente in the United States, where chances
of successful transitional care may be a priori greater due
to the integrated structure of primary, secondary, and
tertiary care and supportive information technology (IT)
systems in a single organization.
Care transitions and readmissions – are we doing
it right?
An especially vulnerable phase in the course of patient
care is the transition between care settings [19], which
necessitates integration of information exchange and
clear delineation of continued care responsibility. It is
well established that patients face significant challenges
in understanding the numerous details involved in hos-
pital discharge instructions, which are often provided
over short periods of time [20,21]. Patients with multiple
chronic conditions consume a majority of inpatient ser-
vices and are especially vulnerable to breakdowns in care
transitions, as their discharge instructions include man-
aging multiple medications and treatments as part of
their continuing care plans. With multimorbidity a con-
sequential risk factor for emergency readmissions, it is
evident that there are significant integration challenges
associated with care transitions of these multi-morbid
patients [22-24].
Reducing readmissions – should we incentivize
reduction via a quality measure?
With recent reforms enacted in the U.S. and other devel-
oped nations, one of the most widely used mechanisms to
reduce readmissions is to establish targets for institutions
(usually hospitals). Setting targets, deriving measurements,
and introducing incentives through compensation or
penalty are widely accepted approaches within the quality
improvement context. Nonetheless, the usefulness of
readmission rates as a quality indicator is much debated.
Those in favor point to its simplicity of measurement and
its comprehensibility and relevance for health care profes-
sionals as well as for policy and decision makers. Several
additional factors point to the advantages in using re-
admission reduction as a quality indicator (or, when rele-
vant, pay-for-performance target):
 Considerable differences are documented between
health care organizations, even when adjusting for
case-mix, providing evidence that at least some
institutions exhibit relatively poor performance [1].
Some of these differences were shown to be closely
associated with different incentives [14].
 Establishing targets and incentives to lower
readmissions rates offers an additional balancing
factor to the volume-driven incentives of fee-for-
service care (as provided in most hospitals in
western countries), where the financial incentive is
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stay). In the optimistic scenario, this will favor more
value-based over volume-based health service
provision.
 In the local Israeli setting, where hospital bed use is
stretched to the limit with a 99% occupancy rate,
much higher than the 76% OECD average (2010
data) [25], any reduction in admissions may reduce
the burden from over-burdened wards and
personnel.
 Attempts to reduce readmissions are likely to
promote patient-centered care that crosses single
institutions’ traditional boundaries. As health care
systems still operate as separate silos, integration
mechanisms, such as readmission assessment, may
serve as an attractive vehicle by which incentives are
"forced" to be aligned in efforts to achieve greater
efficiency and seamless care.
Still, opponents of large-scale adoption of readmission
as a quality indicator raise several concerns.
 Readmissions are not considered medical “never
events”. As a considerable proportion of
readmissions are unavoidable [4], overzealous
attempts to block readmissions may become a
hindrance to the delivery of proper medical care and
to patient safety.
 There is no established definition of a “desirable”
readmission rate, because many aspects of clinical
and social case-mix have a profound impact on
readmission rates, thereby making it very difficult to
set goals for readmission rates. Improper adjustment
may unfairly add financial burden to the institutions
caring for the underprivileged and sicker
populations and the appropriate approach to case-
mix adjustments is still debated [26]. Additionally,
instituting relative goals (reduction from year to
year) tends to penalize the more effective systems
that had lower initial adjusted rates.
 The trade-off of reduced readmissions could be in
increased length of stay. Keeping the patient longer
in the hospital may be attributable to attempts to
provide comprehensive care within the hospital
walls and to achieve better coordination with post-
hospitalization services. Yet, increased length of stay
may also be explained as a means for balancing
reduced occupancy rates as a result of reduced
readmissions.
Policy and practice implications
Some of the abovementioned conceivable shortcomings
of using the rate of readmission as a quality indicator
can be tackled with proper planning and regulation, andallow most of the potential advantages to be gained
while minimizing adverse effects. There are several
examples from which lessons can be drawn to develop
such policies. We discuss lessons from local experiences
within the Israeli health care context as well as from the
international literature.
Some characteristics of potentially effective policies
may include:
 Start slow
Begin with a focused, smaller-size but high-risk
subset of the entire re-admission group. In Israel,
the choice was made by the Ministry of Health
(MoH) to concentrate on internal medicine wards
(which have a 50% higher adjusted risk for
readmissions), and to limit interventions to patients
with a length of stay of 2 nights or more. In the U.S.,
the focus was based on specific clinical diagnostic
groups (such as CHF), a strategy that is less
practical in Israel due to coding insufficiencies
(timing and accuracy).
These subgroups may still be too large for intensive
intervention; additional risk stratification and
targeted intervention strategies may be key to
successful ongoing intervention by healthcare
suppliers.
 Set relative targets
The difficulty in creating fair risk adjustment
mechanisms may result in inequitable target setting.
The most sensible option that does not require
adjustment would be a relative improvement goal
[27]. As current evidence mostly points to success in
narrowly defined populations [5], and large scale
interventions rarely point to reduction of more than
a few percentage points in the rate of readmissions
[28], a goal of 2–4% per year would be reasonable. A
20% reduction in two years, as set by the Israel
MoH, is likely to prove unachievable or non-
sustainable for the larger health plans.
 Do not neglect the community side of the care
transition
Incentives should include and even focus on the
provider responsible for patient care after discharge,
not only the admitting hospital [29]. In Israel, where
there is a clear “home” for every patient for care
provision once discharged (through mandatory
coverage by one of four national health funds [30]),
the decision was made to focus incentives and
measurement on the health plans. In parallel, it is
important to assure through regulation and
incentives that the hospitals will collaborate with the
health plans' efforts to improve transition care
during and after the hospitalization, especially in
view of the potential inherent disincentives.
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outcomes
Quality monitoring and especially implementation of
incentives directed at readmission reduction should
be designed in ways that account for the potential
for increased length of stay, gaming through creative
registration of non-accounted admitting wards, and
other events that may follow from the law of
unintended consequences.
Conclusions
Readmission reduction is an important vehicle to im-
prove efficiency across care settings, and is one of the
few quality measures that, if implemented properly, can
serve as a catalyst for system integration. Appropriate
mechanisms should be applied to hospitals as well as
ambulatory settings to ensure that accountability is
assigned to all stakeholders. Importantly, competing
interests should be resolved as the motivation to fill
hospital beds is still, generally speaking, not offset by
reduced readmission incentives [16].
Israel provides a unique setting of a strong primary care
infrastructure coupled with a unique IT system – full
EMR coverage of community healthcare clinics and an
interoperable data-sharing system with key hospitals. The
successful implementation of community care quality
measurement and quality improvement infrastructure
may serve as an excellent basis for implementing and
assessing advanced interventions for readmission reduc-
tion [31]. In a state of acute bed shortage and a record-
high bed occupancy in the internal wards, all incentives
(including those of most hospitals) are aligned towards re-
ducing preventable readmissions, as evident in the already
relatively low readmission rates. Initial reports of effective
community-hospital collaborations in tackling this com-
plex problem are emerging.
Through sustained support provided by current incen-
tives put forward by the Israeli government, we may
indeed witness implementation of unique integrative
models for tackling this global problem and, hopefully,
unique success stories, emerging from the “start-up
nation”.
Commentary on the paper by Benbassat and Taragin: Effect of Generic
Clinical Interventions on Hospital readmissions: a meta-review of published
meta-analyses and narrative reviews.
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